Work

Mature Results of MM011: A Phase I/II Trial of Lenalidomide, Liposomal Doxorubicin, Dexamethasone, and Vincristine, Followed by Lenalidomide Maintenance (DVd-R) for Relapsed or Refractory Multiple Myeloma

Year: 2010

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v116.21.1967.1967

Authors: Aleksandr Lazaryan, Rachid Baz, Mohamad A Hussein, Paul Elson, Beth Faiman, Becky Habecker, Mary Ann Karam, Janice Reed, Kimberly Hamilton, Kellie Bruening, Gordan Srkalovic, Steven Andresen, Matt Kalaycio, John William Sweetenham, Ronald Sobecks, Robert Dean, Robert Knight, Jerome B. Zeldis, Frederic J. Reu

Institutions: Cleveland Clinic, Moffitt Cancer Center, Celgene (United States), Sparrow Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2585556030

FWCI: 0.2

Cites:

Cited by: 1

Related to: 10